deltatrials
Completed OBSERVATIONAL NCT01441154

Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment

Pharmacokinetic and Pharmacodynamic Studies of Liothyronine. A Study on the Metabolic Effects of Thyroid Hormone

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions Follicular Thyroid Cancer Hurthle Cell Thyroid Cancer Malignant Struma Ovarii Papillary Thyroid Cancer Tall Cell Variant Thyroid Cancer
Updated 20 times since 2017 Last updated: Sep 25, 2020 Started: Sep 20, 2011 Primary completion: Dec 12, 2013 Completion: Dec 12, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01441154, this observational or N/A phase trial focuses on Follicular Thyroid Cancer and Hurthle Cell Thyroid Cancer and remains completed. Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it has been updated 20 times since 2011, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2018 · 14 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Aug 2019 · 5 months · monthly snapshot~Aug 2019 – ~Nov 2019 · 3 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~May 2020 · 5 months · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 21 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Oct 2020 — Jan 2021 [monthly]

    Completed

  5. Aug 2020 — Oct 2020 [monthly]

    Completed

▶ Show 15 earlier versions

  1. Jul 2020 — Aug 2020 [monthly]

    Completed

  2. May 2020 — Jul 2020 [monthly]

    Completed

  3. Dec 2019 — May 2020 [monthly]

    Completed

  4. Nov 2019 — Dec 2019 [monthly]

    Completed

  5. Aug 2019 — Nov 2019 [monthly]

    Completed

  6. Mar 2019 — Aug 2019 [monthly]

    Completed

  7. Jan 2019 — Mar 2019 [monthly]

    Completed

  8. Dec 2018 — Jan 2019 [monthly]

    Completed

  9. Oct 2018 — Dec 2018 [monthly]

    Completed

  10. Sep 2018 — Oct 2018 [monthly]

    Completed

  11. Aug 2018 — Sep 2018 [monthly]

    Completed

  12. Jun 2018 — Aug 2018 [monthly]

    Completed

  13. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  14. Feb 2017 — Apr 2018 [monthly]

    Completed NA

    Phase: PHASE1 → NA

  15. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations